Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMYDA PRIME
2012-003423-37Phase 4Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute ST-segment elevation myocardial infarction (STEMI) comparing Ticagrelor arm with Prasugrel arm (2 arms). Started Aug 2012; status: active.
02
Drugs
ticagrelorprasugrel
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2012-003423-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003423-37.